IRCT20160813029327N20招募中3 期
Evaluation of the efficacy of Fexofenadine in combination with Mebeverine and Mebeverine with placebo in patients with irritable bowel syndrome
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Patients with irritable bowel syndrome based on Rome IV criteria
- •Age between 18-65 years old
- •Informed consent
排除标准
- •Patients with diabetes, cardiovascular diseases, neurological and psychiatric disorders, hepatic disorders, renal failure, Celiac and colitis
- •Pregnancy and lactation
- •History of drug allergy
研究者
相似试验
已完成
不适用
Comparison of therapeutic effects of Fenofibrate and Gemfibrozil on Lipid in patients with DiabetesIRCT201401096710N4Research deputy of Tabriz University of Medical Sciences60
已完成
4 期
A CLINICAL TRIAL ON EFFECT OF SINGLE DOSE FENOFIBRATE AS AN ADJUNCT TO PHOTOTHERAPY IN NEONATAL JAUNDICECTRI/2023/03/050811Deepaa S94
尚未招募
Unknown
A prospective study to compare efficacy of fentanyl versus buprenorphine as an adjuvant to local anaesthetic hyperbaric bupivacaine given in spinal anaesthesia in orthopaedic surgeriesCTRI/2023/03/051128Kallepally Sannidhi
已完成
3 期
Evaluation of efficacy and safety of Fenofibrate in COVID-19 patientsIRCT20220612055149N1Artesh University of Medical Sciences70
已完成
不适用
Effect of Fexofenadine/Pseudoephedrine combination tablet on Nasal Obstruction in Patients with Allergic Rhinitisallergic rhinitisJPRN-UMIN000041845Tottori University24